Eli Lilly pulls ahead of Novo in obesity drug gold rush as new players crowd in
The global weight-loss drug market, once dominated by Novo Nordisk, is undergoing a dramatic transformation. On Friday, the Danish pharmaceutical...
The global weight-loss drug market, once dominated by Novo Nordisk, is undergoing a dramatic transformation. On Friday, the Danish pharmaceutical...
Cox Communications has been a potential takeover target for years. But despite several attempts from multiple suitors, the company always...
Charter Communications has agreed to acquire privately held Cox Communications for $21.9 billion, combining two of the largest cable and...
Reddit co-founder Alexis Ohanian has purchased a minority stake in Chelsea FC Women, giving him an ownership stake in two of...
Nvidia said it won’t be sending graphics processing unit plans to China following a report that the artificial intelligence chipmaker is working on...
Cava on Thursday reported better-than-expected sales in its latest fiscal quarter, shaking off the malaise the broader restaurant industry has felt as...
The Dow Jones Industrial Average has rebounded after crashing to $36,640 in April as concerns about the trade war rose....
A wave of caution swept across Asian trading floors for the second consecutive day on Friday, as investors, finding few...
President Donald Trump’s affinity for grand economic agreements is well-documented, rivaled perhaps only by his preference for low gasoline prices...
Japan witnessed record foreign inflows into its equities and long-term bonds in April, as global investors reacted to US President...
Disclaimer: EarningsMastery.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.